No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa
Related Experiment Video
Updated: Aug 16, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Christopher J Gill1, Davidson H Hamer, Jonathon L Simon
1Center for International Health and Development, Department of International Health, Boston University School of Public Health, MA 02118, USA. cgill@bu.edu
Abstract:
Medication adherence is essential to successful treatment of HIV/AIDS. Maintaining high adherence will likely prove a major challenge in Africa -- just as it has in developed nations. Despite early reports suggesting that adherence would not pose a major barrier to treatment success, more recent research shows that adherence rates in Africa are quite variable and often poor. Given the large number of patients whose disease will progress if adherence is suboptimal, research is urgently needed to determine patient-level behavioral barriers to adherence and the most effective and appropriate methods for assessing adherence in African cohorts.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Amebiasis
Retroviruses
Antiviral Nucleoside Inhibitors
Cryptococcal Meningitis
Subviral Agents

